Mousavi, Seyyed Mojtaba and Hashemi, Seyyed Alireza and Gholami, Ahmad and Kalashgrani, Masoomeh Yari and Vijayakameswara Rao, Neralla and Omidifar, Navid and Hsiao, Wesley Wei-Wen and Lai, Chin Wei and Chiang, Wei-Hung (2022) Plasma-enabled smart nanoexosome platform as emerging immunopathogenesis for clinical viral infection. Pharmaceutics, 14 (5). ISSN 1999-4923, DOI https://doi.org/10.3390/pharmaceutics14051054.
Full text not available from this repository.Abstract
Smart nanoexosomes are nanosized structures enclosed in lipid bilayers that are structurally similar to the viruses released by a variety of cells, including the cells lining the respiratory system. Of particular importance, the interaction between smart nanoexosomes and viruses can be used to develop antiviral drugs and vaccines. It is possible that nanoexosomes will be utilized and antibodies will be acquired more successfully for the transmission of an immune response if reconvalescent plasma (CP) is used instead of reconvalescent plasma exosomes (CPExo) in this concept. Convalescent plasma contains billions of smart nanoexosomes capable of transporting a variety of molecules, including proteins, lipids, RNA and DNA among other viral infections. Smart nanoexosomes are released from virus-infected cells and play an important role in mediating communication between infected and uninfected cells. Infections use the formation, production and release of smart nanoexosomes to enhance the infection, transmission and intercellular diffusion of viruses. Cell-free smart nanoexosomes produced by mesenchymal stem cells (MSCs) could also be used as cell-free therapies in certain cases. Smart nanoexosomes produced by mesenchymal stem cells can also promote mitochondrial function and heal lung injury. They can reduce cytokine storms and restore the suppression of host antiviral defenses weakened by viral infections. This study examines the benefits of smart nanoexosomes and their roles in viral transmission, infection, treatment, drug delivery and clinical applications. We also explore some potential future applications for smart nanoexosomes in the treatment of viral infections.
| Item Type: | Article |
|---|---|
| Funders: | Fundamental Research Grant Scheme (Grant No: FRGS/1/2020/TK0/UM/02/8 & No. FP023-2020), Global Collaborative Programme - SATU Joint Research Scheme (Grant No: ST004-2021) |
| Uncontrolled Keywords: | Viral infections; Convalescent plasma; Smart nanoexosomes; Drug delivery |
| Subjects: | R Medicine > RM Therapeutics. Pharmacology |
| Divisions: | Nanotechnology & Catalysis Research Centre |
| Depositing User: | Ms. Juhaida Abd Rahim |
| Date Deposited: | 13 Oct 2023 07:51 |
| Last Modified: | 13 Oct 2023 07:51 |
| URI: | http://eprints.um.edu.my/id/eprint/42239 |
Actions (login required)
 |
View Item |
